• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[用活化复钙时间监测肝素治疗]

[Monitoring of heparin therapy with activated recalcification time].

作者信息

Lutze G, Schlote A, Urbahn H

出版信息

Z Gesamte Inn Med. 1981 Feb 15;36(4):102-6.

PMID:7222858
Abstract

In in-vivo- and in-vitro-examinations the activated recalcification time, the recalcification time of the plasma, the partial thromboplastin time and the thrombin time were compared concerning their suitability for the control of a heparin therapy. The laboratory methods tested considerably differed in their sensitivity compared with heparin and in the possibility of a quantitative statement. The use of a certain laboratory method depends on the indication for a heparin therapy and on the heparin concentration in the blood to be expected. While thrombin time, recalcification time of the plasma and the partial thromboplastin time are suited only for the proof of lower heparin concentrations, the activated recalcification time allows also the proof of higher heparin concentrations in the blood.

摘要

在体内和体外检查中,比较了活化复钙时间、血浆复钙时间、部分凝血活酶时间和凝血酶时间对肝素治疗控制的适用性。与肝素相比,所测试的实验室方法在敏感性和定量表述可能性方面有很大差异。某种实验室方法的使用取决于肝素治疗的指征以及预期血液中的肝素浓度。虽然凝血酶时间、血浆复钙时间和部分凝血活酶时间仅适用于低肝素浓度的检测,但活化复钙时间也可用于检测血液中较高的肝素浓度。

相似文献

1
[Monitoring of heparin therapy with activated recalcification time].[用活化复钙时间监测肝素治疗]
Z Gesamte Inn Med. 1981 Feb 15;36(4):102-6.
2
[Laboratory controls of heparin therapy with thrombin time, partial thromboplastin time and activated recalcification time].[肝素治疗的实验室控制:凝血酶时间、部分凝血活酶时间和活化复钙时间]
Z Gesamte Inn Med. 1989 Apr 15;44(8):235-40.
3
Clotting, activated partial thromboplastin and coagulation times in monitoring heparin therapy.在监测肝素治疗时的凝血、活化部分凝血活酶时间和凝血时间。
Ann Clin Lab Sci. 1979 Nov-Dec;9(6):494-500.
4
[Monitoring heparin therapy by thrombin time and activated partial thromboplastin time--a comparison].[通过凝血酶时间和活化部分凝血活酶时间监测肝素治疗——一项比较]
Schweiz Med Wochenschr. 1986 Nov 29;116(48):1681-4.
5
[Is the activated partial thromboplastin time suitable for monitoring of thrombosis therapy with high-dose standard heparin?].活化部分凝血活酶时间是否适用于监测大剂量标准肝素的血栓形成治疗?
Schweiz Med Wochenschr. 1994 Apr 30;124(17):712-9.
6
[Monitoring of heparin therapy using thrombin time and activated partial thromboplastin time--a comparison].[使用凝血酶时间和活化部分凝血活酶时间监测肝素治疗——一项比较]
Schweiz Med Wochenschr. 1987 Apr 4;117(14):539-40.
7
[Modification of the global coagulation tests for the dog. Significance for the monitoring of heparin therapy].[犬类全局凝血试验的改良。对肝素治疗监测的意义]
Tierarztl Prax. 1991 Oct;19(5):561-6.
8
[Clinical value of a new method of therapeutic control of heparin].
Arch Inst Cardiol Mex. 1978 Mar-Apr;48(2):373-86.
9
The monitoring of heparin administration by screening tests in experimental dogs.通过筛选试验对实验犬肝素给药进行监测。
Res Vet Sci. 2001 Apr;70(2):101-8. doi: 10.1053/rvsc.2000.0447.
10
Characterization of a new potent heparin. 1 communication: Determinations of anticoagulant activity of a high potency heparin preparation in vivo using dog as an experimental animal and in vitro using dog and human plasma.一种新型高效肝素的特性研究。第一篇通讯:以狗为实验动物,体内测定高效肝素制剂的抗凝活性;以狗和人血浆为样本,体外测定其抗凝活性。
Arzneimittelforschung. 1980;30(6):993-6.